methadone has been researched along with Recrudescence in 170 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 44 (25.88) | 18.7374 |
| 1990's | 34 (20.00) | 18.2507 |
| 2000's | 37 (21.76) | 29.6817 |
| 2010's | 44 (25.88) | 24.3611 |
| 2020's | 11 (6.47) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, J; Hu, F; Li, Q; Li, W; Li, Y; Qin, Y; Shi, H; Wang, L; Wang, W; Wang, Y; Wei, X; Yang, J; Zhu, J | 1 |
| Ahami, AOT; Azzaoui, FZ; Ghailan, T; Idrissi Samlali, W; Karjouh, K | 1 |
| Chawar, C; Hillmer, A; Kapczinski, F; Lamri, A; Pare, G; Samaan, Z; Thabane, L | 1 |
| Angermaier, G; Carswell, N; Castaneda, C; Delgado, F | 1 |
| Chen, W; Fan, C; Ling, L; Liu, Y; Lu, Q; Tang, X; Wang, C; Xu, C; Zhou, W | 1 |
| Díaz, I; Fishman, M; Goodwin, ATS; Luo, S; Nunes, EV; Rotrosen, J; Rudolph, KE; Shulman, M; Williams, NT | 1 |
| Amini, Z; HeidariFarsani, E | 1 |
| Deimel, D; Jamin, D; Keppler, K; Knorr, B; Michels, II; Stöver, H | 1 |
| Abbasnezhad, A; Abd El-Ghafar, OA; Abhilash, L; Abouzid, KAM; Achberger, AM; Ackerman, S; Akhatayeva, Z; Akin, D; Al-Kaysi, RO; Alakhdar, AA; Alame, M; Aleksic Sabo, V; Alinezhadbalalami, N; Allen, JD; Alonso, JM; Alqatani, S; Alsayed, B; Álvarez Larraondo, M; Alvarez, M; Amini, SB; An, Z; Anasir, MI; Anderson, GH; Andremont, A; Andrés, S; Angel, S; Anigboro, AA; Anini, Y; Antonides, CFJ; Arafa, K; Arafa, RK; Aryal, UK; Asbaghi, O; Assefa, MK; Atyah, M; Avwioroko, OJ; Ayora-Talavera, G; Azpilikueta, A; Azyazov, VN; Ba, YF; Bachmann, KF; Badoual, J; Bae, SJ; Baek, SH; Bahrami, B; Bai, J; Baid-Agrawal, S; Bailey, MR; Baillie, JK; Balani, N; Balcar, VJ; Banica, T; Banks, L; Barb, J; Bardeen, CJ; Barrett, HE; Bartnikowski, N; Bashir, R; Battaglia, M; Bautista-Hernández, V; Becker, B; Beekman, FJ; Benidir, M; Benjelloun, M; Bentley, RF; Bergé, J; Berger, D; Bernsen, MR; Berraondo, P; Bhattacharya, R; Bhayani, SB; Bi, W; Bi, X; Bi, YL; Bi, Z; Bian, K; Biesecker, LG; Billadeau, DD; Blaszczyk, R; Blum, JL; Boachie, R; Boelte, K; Bogers, AJJC; Boileau, I; Bonduelle, C; Bonny, O; Bonsu, JM; Boos, LA; Borges-Argáez, R; Bouchard, PA; Boudot, C; Bourgeade-Delmas, S; Boutet-Robinet, E; Boyle, AJ; Branigan, D; Briones, S; Broniowska, KA; Brossas, JY; Brown, WA; Brzezinska, J; Buitron, G; Burnier, M; Bursulaya, B; Burton, PR; Bush, AA; Busuttil, RW; Cabello-Aguilar, S; Cáceres-Farfán, M; Cacheux, V; Caffrey, PJ; Cai, B; Cai, Q; Cai, S; Cai, Y; Calders, P; Cammarota, G; Campbell, DA; Cancelli, C; Cao, Q; Cao, WH; Cao, X; Capet, M; Capoluongo, E; Carey, ME; Carnero, M; Carrasco, LI; Carreno, J; Carrillo-Reyes, J; Casini, I; Cassar, M; Catalan, G; Cattamanchi, A; Cazares-Granillo, M; Celie, B; Cen, YK; Cena, H; Cerbo, RM; Ceron, E; Cetina-Montejo, L; Chaâbane-Banaoues, R; Chabanet, C; Chace-Donahue, F; Chalfun-Júnior, A; Chan-Balan, R; Chang, CS; Chen, CS; Chen, D; Chen, J; Chen, L; Chen, PN; Chen, Q; Chen, S; Chen, W; Chen, WP; Chen, X; Chen, Z; Cheng, H; Cheng, J; Cheng, Q; Cheng, T; Chi, T; Chianelli, D; Chieppa, M; Child, CJ; Cho, JH; Cho, JY; Chogtu, B; Choi, GH; Choi, J; Choi, M; Choi, NG; Cholu, CO; Chow, ES; Chowdhury, AH; Chu, PC; Chu, Q; Chu, S; Chua, H; Chung, T; Chunyan, L; Church, JS; Civardi, E; Cobiella, J; Colinge, J; Collado, CJ; Collins, TJ; Cong, LM; Conkrite, KL; Cope, SJ; Corbett, JA; Cornet, M; Cornillot, E; Corvaisier, S; Costes-Martineau, V; Courtioux, B; Coussens, M; Covino, M; Criado, A; Cui, J; Cui, Y; Cunitz, BW; Curry, AE; Cussó, L; D'Urzo, AD; D'Urzo, KA; Dabbous, S; Dahlgren, RA; Dai, H; Dai, T; Dai, W; Dalinghaus, M; Dang, S; Davalos, RV; Davidson, H; de Andrea, CE; De Angelis, M; de Blois, E; de Carvalho, PA; De Clercq, E; De Giuseppe, R; de Jong, M; De Langhe, S; De Oliveira, L; de Souza Pinto Lemgruber, R; de Souza, LB; de Swart, J; De Wandele, I; de Woestijne, PCV; Delaney, S; Delorme, M; Delvenne, P; Deng, L; Deng, Z; Denkinger, CM; der Meulen, MHV; Deraeve, C; Desco, M; DeSilva, S; Destere, A; Dhali, A; Di Ciano, P; Dias-Santagata, D; Diskin, SJ; Djè, MK; Doddipatla, S; Doerr, AJ; Dokla, EME; Domiciano, D; Domingo, N; Dong, C; Dong, J; Dong, Q; Dong, S; Dong, X; Dong, Z; Douair, I; Douglas, TA; Doyle, SM; Drain, PK; Du, K; Du, L; Du, Q; Du, S; Duan, C; Duan, H; Duan, J; Duan, S; Duan, W; Dueluzeau, R; Dukic, L; Dunmire, BL; Duvauchelle, T; Dymek, B; Dzwonek, K; Earnest, A; Eckardt, KU; El Ghadraoui, L; El Massoudi, S; Elloumi, F; Elnour, IE; Embarak, S; Ende, M; England, K; Enikeev, D; Enyedy, I; Epple, R; Erickson, GE; Eriksson, J; Erndt-Marino, J; Errachidi, F; Etxeberria, I; Evan, AP; Fairlamb, AH; Falahi, E; Fan, CC; Fan, H; Fan, M; Fan, MZ; Fan, S; Fan, Y; Fang, CS; Fang, J; Fang, X; Fang, Z; Farmany, A; Farooqi, A; Farouk, HO; Fazelipour, S; Feng, D; Feng, J; Feng, JX; Feng, YL; Ferraz, SL; Ferreira, CR; Figenshau, RS; Finn, AV; Fiseha, T; Fleischer, AS; Fogleman, AD; Fontaine, O; Ford, CR; Fouladvand, F; Four, M; Fousteri, G; Francis, JR; Fraser, JF; Frazier, RP; Fu, H; Fu, P; Fu, YJ; Fujishima, A; Fuster, V; Gabilan, JC; Gagliani, N; Gai, QY; Galán-Arriola, C; Gale, P; Galimova, GR; Galkin, A; Gallo, A; Gallo, AA; Gang, DD; Ganschow, S; Gao, C; Gao, F; Gao, GP; Gao, H; Gao, K; Gao, M; Gao, MY; Gao, P; Gao, R; Gao, S; Gao, WJ; Gao, Y; Garbacz, P; García Ruiz, L; Garcia, EM; Garofoli, F; Gasbarrini, A; Gattinoni, L; Gaudig, M; Gbureck, U; Ge, X; Genko, N; Gentile, GL; George, MW; Gerety, GF; Gestwicki, JE; Geusens, PP; Ghassemi, M; Giardina, JD; Giebultowicz, JM; Gifford, CA; Gijsen, FJH; Gilfillan, R; Gilson, E; Gingl, K; Giuliano, C; Glybochko, P; Goessler, W; Gofflot, S; Golab, J; Goldstein, A; Golebiowski, A; Gómez, L; Gómez-Carballo, J; Gonçalves, PEO; Gonzales, R; Gonzalez-Cotto, M; González-Fernández, D; Gonzalez-Lopez de Turiso, F; Goodman, JM; Govinda Raju, S; Grimm, J; Gross, AJ; Gruenheid, S; Gu, C; Gu, FF; Gu, S; Gu, Z; Guest, RL; Gui, C; Gui, J; Guillem, A; Guo, G; Guo, L; Guo, Q; Guo, S; Guo, SW; Guo, W; Guo, Y; Guo, YG; Guo, Z; Guretzky, JA; Haenggi, M; Hahn, MS; Hakkola, J; Halim, AA; Hampel, D; Han, B; Han, BH; Han, D; Han, G; Han, J; Han, LZ; Han, R; Han, S; Han, X; Han, Z; Handley, MA; Hanke, I; Hannongbua, S; Hao, P; Happ, JT; Hara, M; Haraux, F; Hare, JL; Harper, JD; Hartley, AM; Harvey, E; Hashimoto, K; Hassan, HM; Hautajärvi, H; Hayton, TW; He, C; He, H; He, HJ; He, WP; He, Y; He, Z; Hedrick, V; Heffernan, JK; Hegrová, J; Heidarimoghadam, R; Helms, K; Hengphasatporn, K; Henry, D; Herrmann, TRW; Hesson, T; Himmelbauer, MK; Hindle, A; Hoffmann, R; Hogg, N; Hong, KB; Hong, SK; Honjol, Y; Hood, C; Hsi, RS; Hsu, JL; Hu, B; Hu, BC; Hu, D; Hu, H; Hu, J; Hu, K; Hu, M; Hu, MK; Hu, T; Hu, W; Hu, Y; Hu, Z; Hua, S; Huang, H; Huang, J; Huang, L; Huang, M; Huang, P; Huang, X; Huang, Y; Huang, Z; Hukkanen, J; Hung, MC; Huo, X; Hyötyläinen, T; Ianiro, G; Ibanez, B; Imran, M; Ireland, S; Irwin, MS; Ishiguro, H; Jackowski, K; Jackson, C; Jacob, SI; Jahromy, MH; Jakob, SM; Jang, J; Javvaji, PK; Jefferson, KK; Jena, P; Ji, H; Jiang, F; Jiang, GH; Jiang, H; Jiang, J; Jiang, X; Jiang, Z; Jiao, J; Jiménez, A; Jin, X; Jincai, W; Jintao, X; Jo, K; Jofra, T; Johari, Y; Johnson, ACM; Jones, JH; Josephine Fauci, A; Juhl, AK; Jun, S; Kaiser, RI; Kajioka, J; Kajiyama, H; Kalliyil, A; Kalthur, SG; Kamalanathan, M; Kamaldinov, T; Kanaani, L; Kang, D; Kang, J; Kang, S; Känsäkoski, P; Kaplan, DL; Karwan, M; Kasibhatla, S; Kaur, A; Kawazoe, Y; Ke, C; Keyser, J; Khalique, A; Khan, IT; Kharshoum, RM; Kher, R; Kherani, J; Ki, KK; Kikkawa, F; Kikkawa, R; Kim, BT; Kim, EH; Kim, GA; Kim, GD; Kim, HB; Kim, HG; Kim, JS; Kim, MJ; Kim, SI; Kim, SJ; Kim, Y; King, K; Kinyamu-Akunda, J; Kirkkala, T; Kjaer-Sorensen, K; Kleppinger, EL; Kloner, RA; Klopfenstein, TJ; Knappe, D; Knezevic, P; Kobos, LM; Kohli, M; Kolano, L; Kolodgie, FD; Kolte, AP; Koneru, B; Kong, D; Kong, F; Kong, X; Konggidinata, MI; Köpke, M; Koski, KG; Kotsis, F; Köttgen, A; Kouakou-Kouamé, CA; Kraemer, US; Krane, V; Krehbiel, CR; Krenning, BJ; Kretzschmar, D; Ku, KB; Kubota, Y; Kulich, P; Kumar, NG; Kupiec-Weglinski, JW; Lalani, SS; Lan, X; Landfeldt, E; Langenberg, E; Lapauw, B; Larkin, J; Lassoued, MA; Laukhtina, E; Laura Martinez, J; Laveillé, A; Lavela, P; Law, AD; Lazraq, A; Le Foll, B; Lee, BK; Lee, C; Lee, CS; Lee, EJ; Lee, EY; Lee, G; Lee, HY; Lee, JH; Lee, JJ; Lee, JO; Lee, JS; Lee, R; Lei, H; Lei, P; Lellouche, F; Lennerz, JK; Leong, W; Leslie, I; Lessem, E; Levin, M; Levinger, I; Li, C; Li, CW; Li, CX; Li, CY; Li, D; Li, H; Li, HM; Li, J; Li, L; Li, LM; Li, N; Li, S; Li, W; Li, X; Li, XX; Li, Y; Li, Z; Li, ZL; Li, ZX; Lian, Q; Liang, C; Liang, GH; Liang, H; Liang, J; Liang, X; Liao, CX; Liao, R; Ličbinský, R; Lim, YS; Lima, HK; Lin, JG; Lin, L; Lin, S; Lin, WP; Lin, Z; Liso, M; Liu, BX; Liu, C; Liu, H; Liu, J; Liu, M; Liu, Q; Liu, S; Liu, SF; Liu, SL; Liu, T; Liu, W; Liu, X; Liu, XB; Liu, Y; Liu, YY; Liu, Z; Liu, ZQ; Lobo, M; Loitzenbauer, M; López, F; Lopez, G; López, GJ; Lou, Z; Lu, IC; Lu, J; Lu, M; Lu, W; Lu, X; Lu, Y; Luhovyy, BL; Luna-Abanto, J; Luo, J; Luo, K; Luo, L; Luo, M; Luo, W; Luo, X; Luo, XM; Lv, Y; Lv, YQ; Lyu, HD; Lyu, J; Ma, C; Ma, G; Ma, L; Ma, Q; Ma, X; Ma, Y; Macha, SJ; MacLean, E; Mahalapbutr, P; Maina, T; Malfait, F; Malfertheiner, MV; Malzert-Fréon, A; Mansouri, E; Mao, C; Marcellin, E; Marchiori, PER; Marcotte, DJ; Maréchal, A; Maric, N; Maris, JM; Maron, L; Marti, CN; Martínez-Milla, J; Mateo, J; Mather, K; Mathison, CJN; Matthay, MA; Maxwell, CL; Mazier, D; Mazumder, D; Mazurkiewicz, M; Mazzucchelli, TG; McAuley, DF; Mccoy, K; McVicar, DW; Mebel, AM; Mech, A; Meester, EJ; Meiselbach, H; Melero, I; Ménard, G; Meng, X; Mengya, Y; Merle, G; Meunier, B; Mfarrej, B; Mi, K; Migueliz, I; Mikuška, P; Miladi, K; Miletich, R; Millar, JE; Mills, MR; Milne, R; Minute, L; Misiak, M; Mo, F; Modi, A; Mok, F; Molina, C; Mollen, CJ; Molteni, V; Montalto, M; Montet, D; Monti, MC; Moor, MB; Moravec, P; Morsiani, C; Murillo, E; Murugan, P; Muslem, R; Myers, RK; N'guessan, FK; Nabil, H; Nadal, J; Nadeem, M; Nafady, MM; Nafie, MS; Nair, HP; Nakano, R; Nance, J; Naren, N; Neil, CJ; Nelson, J; Nery, FC; Netsch, C; Nguyen, TH; Ni, L; Ni, YX; Nie, W; Nielsen, LK; Nigam, K; Nikolayev, AA; Nishiyama, M; Niu, LL; Niu, PP; Nock, BA; Noer, PR; Noll, G; Noll, S; Norenberg, JP; Nowicka, J; Nutho, B; O'Connor, M; Obonyo, NG; Ochiai, T; Ochoa, MC; Oh, BL; Oh, S; Olczak, J; Olivares, X; Ommurugan, B; Oosthuizen, MC; Operario, D; Orešič, M; Oshima, K; Otano, I; Ou, Y; Owen, TW; Oxvig, C; Pacey, V; Pai, M; Paik, H; Paiva, R; Palmieri, EM; Palpant, N; Pan, L; Pan, Q; Panahi, S; Pang, B; Pang, ZC; Pannecouque, C; Paris, L; Park, D; Park, DJ; Park, E; Park, EC; Park, IH; Park, JH; Park, JI; Park, S; Passmore, MR; Pattaranggoon, NC; Paun, M; Pedersen, S; Pedron, J; Peng, M; Peng, X; Penzhorn, BL; Pérez-Camargo, D; Perez-Maldonado, R; Pérez-Vicente, C; Pham, TD; Pickering, L; Pickersgill, NA; Pinault, E; Pinotsis, N; Plan, M; Pocino, K; Poh, CL; Pons, EDC; Popoff, MR; Porri, D; Pourmand, A; Pratviel, G; Prudente, DO; Qi, H; Qi, N; Qian, LY; Qiao, L; Qiao, Q; Qin, QP; Qiu, N; Qiu, SW; Qu, F; Quan, M; Quigg, A; Raee, E; Raibaud, P; Ramanitrahasimbola, D; Rapoport, L; Rasby, RJ; Rasoanirina, BNV; Raspini, B; Ratner, JR; Razafindrakoto, Z; Redd, MA; Ren, H; Ren, N; Rey, J; Reynolds, CP; Rich, PR; Richards, CJ; Rigol, M; Rimoldi, S; Robert, P; Rodrigues, AE; Roe, JH; Rohde, S; Rokita, JL; Roland, J; Rombaut, L; Ronkainen, J; Rothenberg, SM; Roy, SC; Ruan, Z; Rucker, PV; Rueda, D; Ruhwald, M; Rungrotmongkol, T; Rupert, AS; Rusjan, P; Ryabov, AD; Rysä, J; Saad, NES; Sabioni, P; Sadow, PM; Sahai, N; Salem, HF; Salinas, B; Salonurmi, T; Samé Guerra, D; Sánchez, J; Sanchez-González, J; Sanmamed, MF; Sansores-Peraza, P; Santoro, JC; Santschi, PH; Saritas, T; Sarkisova, Y; Savolainen, MJ; Scherberich, JE; Schlom, DG; Schmelz, EM; Schmid, MC; Schneider, MP; Schumacher, S; Schwartz, JC; Schwartzer, JJ; Schwehr, K; Schweitzer, DH; Scott, ME; Sedky, NK; See Hoe, L; Sejian, V; Selvaraju, S; Sen, SK; Seo, G; Šerý, O; Settles, JA; Sfar, S; Shaffer, J; Shan, GL; Shang, Q; Shannahan, JH; Shao, B; Shao, H; Shao, J; Shao, ZH; Shasha, Y; Shaw, K; Sheeba, V; Shekar, K; Shen, G; Shen, H; Shen, XD; Shen, Y; Sherrell, PC; Shete, PB; Shi, AX; Shi, J; Shi, JH; Shi, S; Shi, X; Shigeta, Y; Shimbo, A; Shin, E; Sikka, N; Silhavy, TJ; Simanon, N; Simard, S; Simon, J; Simon, M; Simpson, SD; Simundic, AM; Since, M; Singh, B; Singhroy, DN; Sinisterra, OT; Smith, EH; Sobreira, TJP; Solanes, N; Somasundar, Y; Sommerer, C; Sonei, A; Song, B; Song, E; Song, J; Song, M; Song, Y; Soo Lee, M; Sorensen, MD; Sournia-Saquet, A; Spaepen, E; Spirk, D; Srivastava, S; Stancill, JS; Stanczak, PS; Starenki, D; Starr, F; Step, DL; Steubl, D; Stigliani, JL; Stráská, J; Sträter, N; Su, ZZ; Sudano, I; Suen, JY; Suh, HJ; Sui, ZY; Suico, JG; Suleiman, K; Sumon, K; Sun, HB; Sun, J; Sun, L; Sun, LL; Sun, M; Sun, Q; Sun, W; Sun, X; Sun, XF; Sun, Y; Sun, YB; Sun, YH; Sun, YN; Sun, Z; Sunada, K; Suzuki, S; Sylvan, JB; Takala, J; Talla, D; Tamir, Z; Tan, SJ; Tanda, S; Tang, H; Tang, J; Tang, LF; Tang, SJ; Tang, Y; Tao, FB; Tappel, R; Taratkin, M; Teijeira, Á; Tellew, JE; Thomas, AM; Thomas, SG; Thomson, SR; Tian, J; Tie, Y; Tirado, JL; Tolonen, A; Tosato, G; Tronnet, A; Tsai, S; Turtoi, A; Turtoi, E; Tvrdoňová, M; Tyagi, A; Tzou, DT; Uddin Ahmad, Z; Urias, E; Usawachintachit, M; Ustriyana, P; Utsumi, F; Vacca, M; Vaculovič, T; Vaidya, SS; Valentin, A; Valgepea, K; van den Berg, P; van den Bergh, JP; van der Heiden, K; van Gaalen, K; Van Gemert, W; van Haard, PMM; van Hest, JCM; Vecchiarelli, E; Večeřa, Z; Venkatesh, R; Verhaeghe, P; Verhagen, HJ; Vetter, JM; Vieira, D; Vilchez-Tschischke, JP; Villena-Gutierrez, R; Villoslada Terrones, V; Vital-Jacome, M; Voelkl, J; Vogel, K; Vogrin, S; Volke, D; von Bahr, V; Vysloužil, J; Wade, TL; Wagner-Gillespie, M; Walsh, SW; Wan, LJ; Wan, SP; Wang, AL; Wang, B; Wang, BY; Wang, C; Wang, D; Wang, F; Wang, H; Wang, HR; Wang, HY; Wang, J; Wang, JY; Wang, K; Wang, L; Wang, LF; Wang, P; Wang, Q; Wang, R; Wang, SF; Wang, SP; Wang, SR; Wang, T; Wang, W; Wang, WP; Wang, X; Wang, XJ; Wang, Y; Wang, YL; Wang, YN; Wáng, YXJ; Wang, Z; Wang, ZF; Wang, ZY; Waning, B; Warner, JM; Washington, SL; Watson, AK; Wei, B; Wei, C; Wei, F; Wei, X; Wei, Y; Wemhoff, AP; Wen, Z; Weng, TT; Wesdemiotis, C; Wheeler, DA; Wildner, M; Wilson, BK; Wirth, LJ; Wissler, M; Wu, F; Wu, G; Wu, J; Wu, KH; Wu, MC; Wu, P; Wu, PK; Wu, S; Wu, W; Wu, X; Wu, XP; Wu, Y; Wyatt, E; Wyllie, S; Xia, Y; Xiao, BH; Xiao, SZ; Xiao, W; Xiao, X; Xiao, Z; Xie, D; Xie, K; Xie, X; Xie, Y; Xie, YF; Xin, S; Xin, Z; Xing, Q; Xing, WQ; Xiong, D; Xiong, X; Xu, C; Xu, D; Xu, F; Xu, G; Xu, H; Xu, J; Xu, JY; Xu, L; Xu, N; Xu, W; Xu, X; Xu, Y; Xu, YM; Xue, H; Xue, J; Xue, Z; Yan, R; Yan, SQ; Yan, W; Yan, X; Yan, Z; Yang, C; Yang, D; Yang, F; Yang, FC; Yang, G; Yang, J; Yang, M; Yang, P; Yang, Q; Yang, R; Yang, S; Yang, SJ; Yang, TWW; Yang, X; Yang, Y; Yang, Z; Yao, C; Yao, L; Yao, LP; Yao, M; Yao, T; Yao, W; Yao, Y; Yaseen, T; Yazdani, V; Ye, J; Ye, S; Yerys, BE; Yi, HWL; Yi, JL; Yin, F; Yin, J; Yin, Y; Yin, Z; Yong, ZP; Yongli, S; Yoo, JS; Yoshikawa, N; You, Q; Yu, B; Yu, CQ; Yu, H; Yu, HG; Yu, J; Yu, L; Yu, Q; Yu, X; Yu, Y; Yu, YK; Yu, Z; Yuan, Q; Yuan, R; Yuan, W; Yuan, X; Yuan, Y; Zager, RA; Zagozdzon, A; Zaller, N; Zang, YP; Zappi, ME; Zelikoff, JT; Zeman, T; Zhai, X; Zhan, P; Zhang, B; Zhang, C; Zhang, G; Zhang, H; Zhang, HB; Zhang, J; Zhang, JS; Zhang, L; Zhang, M; Zhang, Q; Zhang, RX; Zhang, S; Zhang, T; Zhang, W; Zhang, WH; Zhang, X; Zhang, XX; Zhang, Y; Zhang, YQ; Zhang, YW; Zhang, Z; Zhang, ZH; Zhao, D; Zhao, FL; Zhao, K; Zhao, L; Zhao, M; Zhao, R; Zhao, S; Zhao, W; Zhao, WG; Zhao, X; Zhao, Y; Zheng, G; Zheng, J; Zheng, S; Zheng, W; Zheng, Y; Zheng, YG; Zhong, Z; Zhou, C; Zhou, D; Zhou, H; Zhou, HY; Zhou, L; Zhou, Q; Zhou, X; Zhou, Y; Zhou, YL; Zhou, Z; Zhu, J; Zhu, L; Zhu, N; Zhu, X; Zhu, XF; Zhu, Y; Zhu, Z | 1 |
| Bertz, JW; Burgess-Hull, AJ; Epstein, DH; Kowalczyk, WJ; Panlilio, LV; Phillips, KA; Preston, KL; Stull, SW | 1 |
| Farnaghi, F; Gholami, N; Hassanian-Moghaddam, H; McDonald, R; Saberi, M; Zamani, N | 1 |
| Hu, F; Li, Q; Li, W; Li, Y; Qin, Y; Shi, H; Wang, L; Wang, W; Wang, Y; Zhu, J | 1 |
| Bertz, JW; Burgess-Hull, AJ; Curtis, BL; Epstein, DH; Lanza, ST; Panlilio, LV; Phillips, KA; Preston, KL; Stull, SW | 1 |
| Altice, FL; Azbel, L; Michels, I; Rozanova, J; Stöver, H | 1 |
| Batres-Y-Carr, T; Thuras, P; Westermeyer, J; Yoon, G | 1 |
| Dennis, ML; Gustafson, DH; Scott, CK | 1 |
| Sewak, R; Spielholz, NI | 1 |
| Dantzler, J; Harper, LM; Kuper, SG; Muir, S; Paddock, CS; Sims, B; Wang, MJ | 1 |
| Carroll, JJ; Green, TC; Rich, JD; Stone, AC | 1 |
| Chen, J; Hu, F; Li, Q; Li, W; Li, Y; Liu, J; Liu, Y; Shi, H; Wang, W; Wang, Y; Wei, X; Ye, J; Zhu, J | 1 |
| Bao, J; Cai, Z; Du, J; Fan, X; Harrington, A; Hu, M; Ning, Z; Shi, D; Zhang, J; Zhang, L; Zhao, M; Zhou, Z | 1 |
| Epstein, DH; Phillips, KA; Preston, KL | 1 |
| Katz, DF; Masoudi, FA; Varosy, PD | 1 |
| Petersson, FJ | 1 |
| Lopez Gonzales, K; Scherbaum, N; Specka, M | 1 |
| Abdollahi, Z; Bahramzad, O; Hamzehgardeshi, Z; Taghizadeh, F | 1 |
| Clark, CB; Cropsey, KL; Hendricks, PS; Lane, PS; Trent, L | 1 |
| Chang, H; Fan, M; Gold, MS; Li, Q; Li, W; Li, Y; Li, Z; Liu, Y; Tian, J; Wang, H; Wang, L; Wang, W; Wang, Y; Yan, X; Zhang, D; Zhang, Y; Zheng, Y; Zhu, J | 1 |
| Adelson, M; Kéri, S; Levy-Gigi, E; Peles, E; Sason, A; Shapiro, AR | 1 |
| Fairbairn, N; Hayashi, K; Kaplan, K; Kerr, T; Suwannawong, P; Ti, L; Wood, E | 1 |
| Bouchkira, H; Remy, AJ; Wenger, H | 1 |
| Aweh, G; Barton, BA; Baxter, JD; Clark, RE; Fisher, WH; O'Connell, E | 1 |
| Chen, J; Li, Q; Li, W; Li, Y; Li, Z; Liu, K; Shi, L; Wang, D; Wang, W; Wang, Y; Xiao, W; Yan, X; Ye, J; Zhu, J | 1 |
| Feng, XS; Jiang, HF; Rong, C; Zhang, J; Zhang, JC; Zhang, LJ; Zhang, RW | 1 |
| Chen, J; Li, Q; Li, W; Li, Y; Li, Z; Liu, J; Wang, W; Wang, Y; Yan, X; Ye, J; Zhu, J | 1 |
| Klein, JW | 1 |
| Altice, F; Barr, E; Chen, E; Conway, B; Dalgard, O; Dore, GJ; Dutko, FJ; Gane, EJ; Gendrano, IN; Grebely, J; Howe, AY; Huang, HC; Litwin, AH; Luetkemeyer, A; Nahass, R; Nguyen, BY; Nickle, DC; Peng, CY; Platt, HL; Robertson, MN; Shibolet, O; Wahl, J | 1 |
| Chang, H; Chen, J; Li, Q; Li, W; Li, Y; Li, Z; Liu, J; Shi, M; Wang, W; Wang, Y; Ye, J; Zhu, J | 1 |
| Alagoz, E; Gustafson, DH; Johnson, RA; Kornfield, R; Landucci, G; Mares, ML; McTavish, F; Pe-Romashko, K; Quanbeck, A; Shah, D; Thomas, C; Westergaard, RP | 1 |
| Altice, FL; Kamarulzaman, A; Kaur, S; Osornprasop, S; Rajandaran, V; Wegman, MP; Wilson, D; Wilson, DP | 1 |
| O'Brien, CP | 1 |
| Ilgen, M; Jain, A; Kim, HM; Trafton, JA | 1 |
| Hershberger, J; Joseph, H; Lee, JD; Magura, S; Marsch, L; Rosenblum, A; Shropshire, C | 1 |
| Bacosi, D; Baldelli, F; Belfiori, B; Chiodera, A; Ciliegi, P; Francisci, D; Tosti, A | 1 |
| Cohen, LJ; Davey, EE; Eisenberg, D; Galynker, II; London, ED; Prosser, JM; Steinfeld, M | 1 |
| Bao, YP; Epstein, DH; Liu, TT; Lu, L; Shi, J | 1 |
| Epstein, DH; Lin, JL; Mezghanni, M; Preston, KL; Vahabzadeh, M; Willner-Reid, J | 1 |
| Hunault, C; Marzo, JN; Meroueh, F; Obradovic, I; Rotily, M; Varastet, M; Zin, A | 1 |
| Ignjatova, L; Raleva, M | 1 |
| Anis, AH; Fischer, B; MacNab, YC; Marsh, DC; Nosyk, B; Schechter, MT; Sun, H | 1 |
| Calderone, M; Da Dalt, L; Laverda, AM; Masiero, S; Severino, MS; Zanin, A | 1 |
| Agar, MH; Brown, BS; Kelly, SM; Marrari, EA; Mitchell, SG; O'Grady, KE; Peterson, JA; Reisinger, HS; Schwartz, RP | 1 |
| Föhn, M; Oehy, K; Vetter, M; Wedler, V | 1 |
| Epstein, DH; Preston, KL | 1 |
| Bresani, E; Carpenedo, CM; Dugosh, KL; Kirby, KC; Rosenwasser, BJ; Versek, BE | 1 |
| Weich, L | 1 |
| Barry, J; Ducray, K; Keenan, E; Smyth, BP | 1 |
| Krupitsky, E; O'Brien, CP; Woody, GE; Zvartau, E | 1 |
| Greanya, ED; Haque, M; Jiao, M; Soos, JG; Yoshida, EM | 1 |
| Auriacombe, M; Denis, C; Fatseas, M; Franques-Rénéric, P; Massida, Z; Verger, M | 1 |
| Chang, YJ; Du, J; Evans, E; Hser, YI; Huang, D; Jiang, H; Li, J; Peng, C; Roll, J; Stitzer, ML; Wu, F; Zhang, B; Zhang, C; Zhang, R; Zhao, M | 1 |
| Burns, L; Dolan, K; Larney, S; Toson, B | 1 |
| Du, J; Fu, L; Hser, YI; Wu, F; Zhao, M | 1 |
| Jovanović, T; Lazarević, D; Nikolić, G | 1 |
| Cockayne, L; McKeganey, N; Russell, C | 1 |
| Chen, KC; Chen, PS; Hsieh, PC; Lee, SY; Lin, SH; Lu, RB; Yang, YK | 1 |
| Buster, MC; van Brussel, GH; van den Brink, W | 1 |
| Blatier, C; Levasseur, L; Marzo, JN; Ross, N | 1 |
| Epstein, DH; Gupman, AE; Preston, KL; Schroeder, JR; Umbricht, A | 1 |
| McCool, RM; Paschall Richter, K | 1 |
| Grella, CE; Hser, YI; Hsieh, SC | 1 |
| Atanda, A; Barnett, R; DePiano, M; Lynch, KG; Olthoff, KM; Weinrieb, RM | 1 |
| Bell, J; Burrell, T; Gilmour, S; Indig, D | 1 |
| Clarke, J; Key, RG; McKenzie, M; Poshkus, M; Rich, JD; Shield, DC; Wolf, FA | 1 |
| Celentano, DD; Galai, N; Shah, NG; Strathdee, SA; Vlahov, D | 1 |
| Alford, DP; Compton, P; Samet, JH | 1 |
| Amodeo, M; Lundgren, LM; Sullivan, L | 1 |
| Challacombe, L; Fischer, B; Hopkins, S; Millson, P; Myers, T; Shore, R; Strike, CJ; Villeneuve, PJ | 1 |
| Galarneau, DW; Kellogg, S; Khuri, E; Kreek, MJ; Leon, AC; Lilly, C; Melia, D; Teres, JJ | 1 |
| Fireman, M; Hauser, P; Matthews, AM; Sobel, M; Zucker, B | 1 |
| Bearn, J; Best, D; Beswick, T; Gossop, M; McCambridge, J; Rees, S; Strang, J | 1 |
| Fitzsimons, HE; Jones, HE; Tuten, M; Vaidya, V | 1 |
| Beck, O; Helander, A; Leifman, A; Romelsjö, A; Stenbacka, M | 1 |
| Hurlé, MA; Martínez-Cué, C; Tramullas, M | 1 |
| McKenzie, M; Rich, JD; Schwartz, RP | 1 |
| Hollonds, GB; Oei, TP; Turecek, LR | 1 |
| Childress, AR; Ehrman, RN; McLellan, AT; O'Brien, CP; Ternes, J | 1 |
| Goldstein, A; Judson, BA | 1 |
| Camí Morell, J | 1 |
| Anglin, MD; McGlothlin, WH | 1 |
| Chaney, EF; Cummings, C; Roszell, DK | 1 |
| Grönbladh, L; Gunne, LM | 1 |
| Krueger, DW | 1 |
| Savage, LJ; Simpson, DD | 1 |
| Powell, J | 1 |
| Bell, J; Chan, J; Kuk, A | 1 |
| Reisinger, M | 1 |
| Boissonnas, A | 1 |
| Bigelow, GE; Liebson, IA; Stitzer, ML; Strain, EC | 1 |
| Joe, GW; Sells, SB; Simpson, DD | 1 |
| Ralston, GE; Watson, R; Wilson, P | 1 |
| Hoffman, JA; Moolchan, ET | 1 |
| Anglin, D; Hser, YI; Powers, K | 1 |
| De Leon, G; Kang, SY | 1 |
| Condelli, WS; Dunteman, GH | 1 |
| Anglin, MD; Brecht, ML; Wang, JC | 1 |
| Newman, RG | 2 |
| Avants, SK; Kosten, TR; Margolin, A | 1 |
| Batki, SL; Herbst, MD; Jones, T; Manfredi, LB | 1 |
| Ehrenreich, H; Poser, W | 1 |
| Catalano, RF; Gainey, RR; Haggerty, KP; Hoppe, MJ | 1 |
| Demsky, S; Kang, SY; Magura, S; Nwakeze, PC | 1 |
| Broers, B; Voegeli, JP | 1 |
| Amin, H; Kranzler, HR; Modesto-Lowe, V; Oncken, C | 1 |
| Alterman, A; Cacciola, J; Merrill, J; Rutherford, M | 1 |
| Chawarski, MC; Pakes, J; Pantalon, MV; Schottenfeld, RS | 1 |
| Coutinho, RA; Langendam, MW; van Ameijden, EJ; van Brussel, GH | 1 |
| Desmond, DP; Zule, WA | 1 |
| Calsyn, DA; Fleming, C; Saxon, AJ; Wells, EA | 1 |
| Broers, B; Giner, F; Mino, A; Perneger, TV | 1 |
| Nolan, J; Shuman, HI; Swanson, AJ; Tomasino, V | 1 |
| Mutasa, HC | 1 |
| Elms, RR; Thomson, CP; Wilson, BK | 1 |
| Jarvik, ME; Sideroff, SI | 1 |
| Kestenbaum, RS; Resnick, RB; Thomas, MA; Washton, AM | 1 |
| Khuri, ET; Millman, RB; Nyswander, ME | 1 |
| Cushman, P | 1 |
| Cohen, M; Goldberg, J; Rotkopf, E; Stimmel, B | 2 |
| Dole, VP; Joseph, H | 1 |
| Klein, DF | 1 |
| del Campo, EJ; John, DS; Kauffman, CC | 1 |
| Kleber, HD; Mezritz, M; Riordan, CE; Slobetz, F | 1 |
| Lal, B; Singh, G | 1 |
| Dunckley, TE; Sechrest, DK | 1 |
| Ding, MG; Oei, TP; Vajda, JA | 1 |
| Goldstein, A | 2 |
| Gossop, M; Strang, J; Unnithan, S | 1 |
| Behr, HM; Carroll, KM; Chang, G; Kosten, TR | 1 |
| Schuler, S | 1 |
| Hall, SM; Havassy, BE; Wasserman, DA | 1 |
| Ledoux, Y; Pelc, I; Roussaux, JP; Simonart, C; Snoy, T | 1 |
| Cooper, JR | 1 |
| Gastpar, M; Scherbaum, N | 1 |
| Dhopesh, V; Manny, I; O'Conor, LM; Woody, G; Yeh, HS | 1 |
| Di Giannantonio, M; Persico, AM; Tempesta, E | 1 |
| Hubbard, RL; Joe, GW; Simpson, DD | 1 |
| Hermalin, JA; Metzger, DS; Platt, JJ; Steer, RA | 1 |
| Camerone, E; Francesetti, G; Ganora, D; Meluzzi, A; Ravizza, L | 1 |
| Bradley, B; Gossop, M; Green, L; Phillips, G | 1 |
| Bradley, BP; Gossop, M; Green, L; Phillips, G | 1 |
| Moring, J; Strang, J | 1 |
| Childress, AR; Ehrman, R; McLellan, AT; O'Brien, CP | 1 |
| Anglin, MD; Fisher, DG | 2 |
| Kleber, HD; Kosten, TR; Rounsaville, BJ | 1 |
| Furlan, PM; Meluzzi, A; Pelissero, E; Ravizza, L; Zanin, L | 1 |
| Sutker, PB | 1 |
| Rabin, J; Stimmel, B | 1 |
| Bowden, CL; Maddux, JF | 1 |
| Dole, VP | 1 |
| Blachly, PH | 1 |
| Cassidy, WJ | 1 |
| Kumar, R; Stolerman, IP | 1 |
| Davidson, GE; Patch, VD; Rosenberg, CM | 1 |
| Gearing, FR | 1 |
| Vaillant, GE | 1 |
12 review(s) available for methadone and Recrudescence
| Article | Year |
|---|---|
Management of opioid withdrawal and initiation of medications for opioid use disorder in the hospital setting.
Topics: Analgesics, Opioid; Antiemetics; Benzodiazepines; Buprenorphine; Hospitals; Humans; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Recurrence; Substance Withdrawal Syndrome; United States | 2022 |
Opioid substitution therapy for people living in German prisons-inequality compared with civic sector.
Topics: Delivery of Health Care; Female; Germany; Healthcare Disparities; Hepatitis C, Chronic; HIV Infections; Humans; Illicit Drugs; Male; Methadone; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Prisons; Recurrence; Risk Factors | 2019 |
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus | 2016 |
Opioid Detoxification in Pregnancy: Systematic Review and Meta-Analysis of Perinatal Outcomes.
Topics: Analgesics, Opioid; Buprenorphine; Female; Humans; Infant, Newborn; Methadone; Neonatal Abstinence Syndrome; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Premature Birth; Recurrence | 2019 |
Pharmacotherapy for Substance Use Disorders.
Topics: Age Factors; Alcohol Deterrents; Alcoholism; Antidepressive Agents; Buprenorphine; Bupropion; Drug Therapy, Combination; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Recurrence; Substance Withdrawal Syndrome; Substance-Related Disorders; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2016 |
A meta-analysis of acupuncture combined with opioid receptor agonists for treatment of opiate-withdrawal symptoms.
Topics: Acupuncture Therapy; Adult; Analgesics, Opioid; Combined Modality Therapy; Humans; Male; Medicine, Chinese Traditional; Methadone; Opioid-Related Disorders; Randomized Controlled Trials as Topic; Receptors, Opioid; Recurrence; Substance Withdrawal Syndrome; Treatment Outcome; Young Adult | 2009 |
Methadone maintenance therapy in liver transplantation.
Topics: Analgesia; Contraindications; Drug Monitoring; Evidence-Based Practice; Feasibility Studies; Graft Survival; Health Services Accessibility; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Liver Transplantation; Methadone; Narcotics; North America; Patient Selection; Perioperative Care; Recurrence; Risk Factors; Substance Abuse, Intravenous; Survival Rate | 2010 |
Acute pain management for patients receiving maintenance methadone or buprenorphine therapy.
Topics: Acute Disease; Adult; Analgesics, Opioid; Buprenorphine; Female; Heroin Dependence; Humans; Methadone; Narcotic Antagonists; Pain; Recurrence; Ulna Fractures | 2006 |
Opioid addiction and incarceration: an overview.
Topics: Analgesics, Opioid; Chronic Disease; Criminal Law; Forensic Psychiatry; Humans; Methadone; Opioid-Related Disorders; Prisoners; Prisons; Recurrence; Rhode Island; Substance Abuse Treatment Centers | 2007 |
[Naltrexone--prevention of recurrence in narcotic dependence and in alcoholism].
Topics: Alcoholism; Delayed-Action Preparations; Follow-Up Studies; Heroin Dependence; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Recurrence; Treatment Outcome | 1996 |
Pharmacologic treatments for drug and alcohol dependence.
Topics: Alcohol Deterrents; Alcoholism; Antidepressive Agents; Antipsychotic Agents; Carbamazepine; Cocaine-Related Disorders; Female; Humans; Male; Methadone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Recurrence; Substance-Related Disorders; Tobacco Use Disorder | 1999 |
[Methadone maintenance as a therapeutic approach in the treatment of opiate dependent patients].
Topics: Follow-Up Studies; Germany; Humans; Methadone; Opioid-Related Disorders; Recurrence | 1991 |
21 trial(s) available for methadone and Recrudescence
| Article | Year |
|---|---|
Investigating the effect of zinc supplementation on probability of relapse and mental health in patients with opioid use disorder undergoing methadone maintenance treatment.
Topics: Dietary Supplements; Humans; Iran; Mental Health; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Recurrence; Zinc | 2023 |
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus | 2016 |
Using ecological momentary assessments to predict relapse after adult substance use treatment.
Topics: Adult; Affective Symptoms; Ambulatory Care; Chicago; Craving; Ecological Momentary Assessment; Female; Humans; Internal-External Control; Male; Methadone; Middle Aged; Recurrence; Residential Treatment; Risk Factors; Smartphone; Substance-Related Disorders | 2018 |
Relapse prevention: Using sound to reduce the probability of recidivism and suffering following detoxification.
Topics: Adult; Analgesics, Opioid; Behavior, Addictive; Brain; Female; Florida; Humans; Male; Methadone; Middle Aged; Music Therapy; Narcotics; Neuronal Plasticity; Opioid-Related Disorders; Pilot Projects; Probability; Quality of Life; Recidivism; Recurrence; Reward; Secondary Prevention; Substance-Related Disorders; Young Adult | 2018 |
Factors Associated with Relapse among Heroin Addicts: Evidence from a Two-Year Community-Based Follow-Up Study in China.
Topics: Adolescent; Adult; Aged; Analgesics, Opioid; China; Cohort Studies; Combined Modality Therapy; Counseling; Female; Follow-Up Studies; Heroin Dependence; Humans; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Patient Compliance; Recurrence; Risk Factors; Secondary Prevention; Social Support; Treatment Outcome; Young Adult | 2016 |
Elbasvir-Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy: A Randomized Trial.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Benzofurans; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Double-Blind Method; Drug Combinations; Drug Resistance, Viral; Female; Genotype; Hepatitis C, Chronic; Humans; Imidazoles; Male; Medication Adherence; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Quinoxalines; Recurrence; Substance Abuse, Intravenous; Young Adult | 2016 |
The effect of bundling medication-assisted treatment for opioid addiction with mHealth: study protocol for a randomized clinical trial.
Topics: Adaptation, Psychological; Analgesics, Opioid; Buprenorphine; Clinical Protocols; Combined Modality Therapy; Drug Users; Health Services Accessibility; Humans; Methadone; Mobile Applications; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Quality of Life; Recurrence; Research Design; Smartphone; Telemedicine; Time Factors; Treatment Outcome; Wisconsin | 2016 |
The effect of stress on craving for methadone depends on the timing of last methadone dose.
Topics: Behavior, Addictive; Cold Temperature; Female; Heroin Dependence; Humans; Male; Methadone; Middle Aged; Recurrence; Stress, Psychological; Substance Withdrawal Syndrome; Task Performance and Analysis; Time Factors | 2008 |
Buprenorphine and methadone maintenance in jail and post-release: a randomized clinical trial.
Topics: Adolescent; Adult; Aged; Buprenorphine; Diagnosis, Dual (Psychiatry); Female; Follow-Up Studies; HIV Infections; Humans; Male; Mental Disorders; Methadone; Middle Aged; Narcotics; Opioid-Related Disorders; Patient Selection; Prisons; Recurrence; Socioeconomic Factors; Treatment Outcome; Young Adult | 2009 |
Cue-induced reactivity, cortisol response and substance use outcome in treated heroin dependent individuals.
Topics: Adult; Buprenorphine; Cues; Drug-Seeking Behavior; Female; Galvanic Skin Response; Heroin Dependence; Humans; Hydrocortisone; Logistic Models; Male; Methadone; Opiate Substitution Treatment; Recurrence; Saliva | 2011 |
Effects of a randomized contingency management intervention on opiate abstinence and retention in methadone maintenance treatment in China.
Topics: Adult; Analysis of Variance; China; Female; HIV Infections; Humans; Male; Methadone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Compliance; Patient Dropouts; Recurrence; Reward; Substance Abuse, Intravenous; Time Factors; Treatment Outcome | 2011 |
Pilot trial of a recovery management intervention for heroin addicts released from compulsory rehabilitation in China.
Topics: Adult; China; Employment; Female; Follow-Up Studies; Heroin Dependence; Humans; Male; Mandatory Programs; Methadone; Middle Aged; Opiate Substitution Treatment; Pilot Projects; Recurrence; Substance Abuse Detection; Time Factors | 2013 |
Medically assisted recovery from opiate dependence within the context of the UK drug strategy: methadone and Suboxone (buprenorphine-naloxone) patients compared.
Topics: Adult; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Female; Follow-Up Studies; Health Policy; Heroin Dependence; Humans; Male; Methadone; Naloxone; Opiate Substitution Treatment; Opioid-Related Disorders; Recurrence; Time Factors; Treatment Outcome; United Kingdom | 2013 |
Do noncontingent vouchers increase drug use?
Topics: Adult; Cocaine-Related Disorders; Dose-Response Relationship, Drug; Female; Humans; Logistic Models; Male; Methadone; Narcotics; Opioid-Related Disorders; Psychiatric Status Rating Scales; Recurrence; Risk Assessment; Substance Abuse Detection; Substance-Related Disorders; Treatment Outcome | 2003 |
In-patient detoxification procedures, treatment retention, and post-treatment opiate use: comparison of lofexidine + naloxone, lofexidine + placebo, and methadone.
Topics: Adolescent; Adrenergic alpha-Agonists; Adult; Analgesics, Opioid; Clonidine; Cohort Studies; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Length of Stay; Male; Methadone; Middle Aged; Naloxone; Narcotic Antagonists; Opioid-Related Disorders; Recurrence; Substance Abuse Treatment Centers; Substance Withdrawal Syndrome; Treatment Outcome | 2007 |
The Swedish methadone maintenance program: a controlled study.
Topics: Adult; Female; Heroin Dependence; Humans; Male; Methadone; Recurrence; Sweden | 1981 |
Investigating the influence of treatment philosophy on outcome of methadone maintenance.
Topics: Adult; Aftercare; Cohort Studies; Dose-Response Relationship, Drug; Female; Heroin Dependence; Humans; Long-Term Care; Male; Methadone; New South Wales; Organizational Policy; Recurrence; Substance Abuse Treatment Centers; Substance Withdrawal Syndrome; Treatment Outcome | 1995 |
Outcome after methadone treatment: influence of prior treatment factors and current treatment status.
Topics: Adult; Combined Modality Therapy; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Methadone; Opioid-Related Disorders; Psychotherapy, Group; Recurrence; Rehabilitation, Vocational; Substance Abuse Detection; Treatment Outcome | 1994 |
Mazindol for relapse prevention to cocaine abuse in methadone-maintained patients.
Topics: Adult; Cocaine; Combined Modality Therapy; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Mazindol; Methadone; Narcotic Antagonists; Psychotherapy; Recurrence; Substance-Related Disorders | 1995 |
Patterns of opiate use in a heroin maintenance programme.
Topics: Adult; Age Factors; Anti-Anxiety Agents; Clorazepate Dipotassium; Female; Follow-Up Studies; Heroin Dependence; Humans; Male; Methadone; Morphine; Narcotics; Recurrence; Risk Factors | 2000 |
Outpatient vs hospital methadone detoxification: an experimental comparison.
Topics: Administration, Oral; Adult; Ambulatory Care; Aspartate Aminotransferases; Costs and Cost Analysis; Counseling; Hospitalization; Humans; Length of Stay; Liver; Methadone; Outpatient Clinics, Hospital; Palliative Care; Personality Disorders; Recurrence; Substance-Related Disorders; Time Factors | 1975 |
138 other study(ies) available for methadone and Recrudescence
| Article | Year |
|---|---|
Relapse risk revealed by degree centrality and cluster analysis in heroin addicts undergoing methadone maintenance treatment.
Topics: Brain; Heroin; Heroin Dependence; Humans; Male; Methadone; Opiate Substitution Treatment; Recurrence | 2023 |
[Early maladaptive schemes and relapse during methadone maintenance treatment among drug addicts (a cognitive approach)].
Topics: Adaptation, Psychological; Cognition; Cross-Sectional Studies; Drug Users; Female; Heroin Dependence; Humans; Male; Methadone; Recurrence; Surveys and Questionnaires | 2022 |
Implications of OPRM1 and CYP2B6 variants on treatment outcomes in methadone-maintained patients in Ontario: Exploring sex differences.
Topics: Adult; Alleles; Analgesics, Opioid; Cytochrome P-450 CYP2B6; Female; Gene Frequency; Genotype; Humans; Linkage Disequilibrium; Male; Methadone; Ontario; Opiate Substitution Treatment; Opioid-Related Disorders; Polymorphism, Single Nucleotide; Receptors, Opioid, mu; Recurrence; Sex Characteristics; Sex Factors; Substance-Related Disorders; Treatment Outcome | 2021 |
Exploration of dose tapering strategies for methadone maintenance treatment based on relapse risks: A subpopulation treatment effect pattern plot (STEPP) analysis.
Topics: China; Drug Tapering; Humans; Methadone; Opiate Substitution Treatment; Recurrence; Retrospective Studies | 2022 |
Buprenorphine & methadone dosing strategies to reduce risk of relapse in the treatment of opioid use disorder.
Topics: Analgesics, Opioid; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Humans; Methadone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Recurrence | 2022 |
Beyond abstinence and relapse: cluster analysis of drug-use patterns during treatment as an outcome measure for clinical trials.
Topics: Adult; Behavior Therapy; Clinical Trials as Topic; Cluster Analysis; Cocaine-Related Disorders; Female; Humans; Male; Methadone; Middle Aged; Opioid-Related Disorders; Outcome Assessment, Health Care; Recurrence; Treatment Outcome | 2020 |
A study of the effectiveness of naltrexone in preventing recurrence of methadone poisoning in opioid-naive children.
Topics: Adolescent; Aftercare; Analgesics, Opioid; Child; Child, Preschool; Female; Hospitalization; Humans; Infant; Intensive Care Units; Iran; Male; Methadone; Naloxone; Naltrexone; Narcotic Antagonists; Narcotics; Neoplasms; Patient Discharge; Poisoning; Recurrence; Retrospective Studies | 2021 |
Altered brain intrinsic functional hubs and connectivity associated with relapse risk in heroin dependents undergoing methadone maintenance treatment: A resting-state fMRI study.
Topics: Adult; Brain; Brain Mapping; Cerebral Cortex; Chronic Disease; Female; Heroin; Heroin Dependence; Humans; Magnetic Resonance Imaging; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Prefrontal Cortex; Recurrence | 2021 |
Beyond abstinence and relapse II: momentary relationships between stress, craving, and lapse within clusters of patients with similar patterns of drug use.
Topics: Affect; Buprenorphine; Cocaine-Related Disorders; Craving; Ecological Momentary Assessment; Female; Humans; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Recurrence; Smartphone; Stress, Psychological | 2021 |
A qualitative assessment of an abstinence-oriented therapeutic community for prisoners with substance use disorders in Kyrgyzstan.
Topics: Adult; Attitude; Female; Humans; Kyrgyzstan; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Acceptance of Health Care; Prisoners; Prisons; Recurrence; Therapeutic Community; Treatment Outcome | 2017 |
Long QTc During Methadone Maintenance: Contributors and Interventions Over 4 Years.
Topics: Adult; Aged; Analgesics, Opioid; Electrocardiography; Humans; Long QT Syndrome; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Prevalence; Recurrence | 2017 |
Methadone maintenance treatment among patients exposed to illicit fentanyl in Rhode Island: Safety, dose, retention, and relapse at 6 months.
Topics: Adult; Analgesics, Opioid; Dose-Response Relationship, Drug; Drug Overdose; Female; Fentanyl; Humans; Illicit Drugs; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Recurrence; Retrospective Studies; Rhode Island; Treatment Outcome | 2018 |
The polymorphism of dopamine D2 receptor TaqIA gene is associated with brain response to drug cues in male heroin-dependent individuals during methadone maintenance treatment.
Topics: Adult; Alleles; Analgesics, Opioid; Brain; Craving; Cues; Heroin; Heroin Dependence; Humans; Magnetic Resonance Imaging; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Pharmacogenomic Variants; Polymorphism, Genetic; Receptors, Dopamine D2; Recurrence; Reward | 2019 |
Mixed methods to explore factors associated with the decline of patients in the methadone maintenance treatment program in Shanghai, China.
Topics: Adolescent; Adult; Aged; Amphetamine-Related Disorders; Analgesics, Opioid; China; Female; Focus Groups; Health Knowledge, Attitudes, Practice; Heroin Dependence; HIV Infections; Humans; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Patient Dropouts; Qualitative Research; Recurrence; Young Adult | 2019 |
Daily temporal patterns of heroin and cocaine use and craving: relationship with business hours regardless of actual employment status.
Topics: Activities of Daily Living; Adolescent; Adult; Aged; Analgesics, Opioid; Cocaine-Related Disorders; Data Collection; Employment; Female; Heroin Dependence; Humans; Linear Models; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Periodicity; Prospective Studies; Recurrence; Self Report; Social Conformity; Time Factors; Young Adult | 2013 |
Syncope: a tale of two triggers.
Topics: Bradycardia; Dose-Response Relationship, Drug; Electrocardiography; Humans; Male; Methadone; Middle Aged; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Recurrence; Syncope; Torsades de Pointes; Urination Disorders; Ventricular Premature Complexes | 2013 |
Excusing exclusion: Accounting for rule-breaking and sanctions in a Swedish methadone clinic.
Topics: Analgesics, Opioid; Attitude of Health Personnel; Cooperative Behavior; Dangerous Behavior; Decision Making; Drug Users; Health Knowledge, Attitudes, Practice; Heroin Dependence; Humans; Methadone; Opiate Substitution Treatment; Patient Care Team; Patient Compliance; Program Development; Program Evaluation; Punishment; Recurrence; Social Responsibility; Substance Abuse Treatment Centers; Sweden; Treatment Outcome | 2013 |
[Outcomes of comprehensive inpatient opiate detoxification in patients re-admitted to treatment within one year].
Topics: Adult; Aftercare; Clonidine; Comorbidity; Comprehensive Health Care; Female; Germany; Heroin Dependence; Humans; Male; Mental Disorders; Methadone; Middle Aged; Opiate Substitution Treatment; Patient Admission; Patient Dropouts; Patient Readmission; Recurrence; Treatment Outcome; Young Adult | 2015 |
Relationship between addiction relapse and self-efficacy rates in injection drug users referred to Maintenance Therapy Center of Sari, 1391.
Topics: Adult; Age Factors; Cross-Sectional Studies; Female; Humans; Iran; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Recurrence; Self Efficacy; Socioeconomic Factors; Substance Abuse, Intravenous; Time Factors; Treatment Outcome | 2014 |
Methadone maintenance treatment may improve completion rates and delay opioid relapse for opioid dependent individuals under community corrections supervision.
Topics: Adult; Analgesics, Opioid; Analysis of Variance; Criminal Law; Criminals; Female; Humans; Interviews as Topic; Male; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Compliance; Recurrence; Residence Characteristics; Treatment Outcome | 2014 |
Predicting subsequent relapse by drug-related cue-induced brain activation in heroin addiction: an event-related functional magnetic resonance imaging study.
Topics: Adult; Brain; Brain Mapping; China; Cues; Female; Follow-Up Studies; Heroin Dependence; History, Ancient; Humans; Magnetic Resonance Imaging; Male; Methadone; Opiate Substitution Treatment; Predictive Value of Tests; Prospective Studies; Recurrence; Reproducibility of Results | 2015 |
Methadone maintenance patients show a selective deficit to reverse positive outcomes in drug-related conditions compared to medication free prolonged opiate abstinence.
Topics: Adult; Analgesics, Opioid; Behavior, Addictive; Female; Humans; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Photic Stimulation; Recurrence; Self Report; Treatment Outcome | 2014 |
Compulsory drug detention and injection drug use cessation and relapse in Bangkok, Thailand.
Topics: Adult; Cross-Sectional Studies; Female; Health Policy; HIV Infections; Humans; Logistic Models; Male; Mandatory Programs; Methadone; Middle Aged; Multivariate Analysis; Prevalence; Prisons; Recurrence; Substance Abuse Treatment Centers; Substance Abuse, Intravenous; Thailand; Time Factors | 2015 |
[Treatment of chronic hepatitis C in drug users: ethic, successful and useful].
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Buprenorphine; Comorbidity; Cooperative Behavior; Cross-Sectional Studies; Ethics, Medical; Follow-Up Studies; France; Health Services Accessibility; Hepatitis C, Chronic; Humans; Interdisciplinary Communication; Methadone; Patient Care Team; Prisoners; Recurrence; Substance Abuse Detection; Substance Abuse Treatment Centers; Substance Abuse, Intravenous; Utilization Review | 2014 |
Risk Factors for Relapse and Higher Costs Among Medicaid Members with Opioid Dependence or Abuse: Opioid Agonists, Comorbidities, and Treatment History.
Topics: Adult; Analgesics, Opioid; Behavior Therapy; Buprenorphine; Combined Modality Therapy; Comorbidity; Female; Health Care Costs; Humans; Male; Medicaid; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Recurrence; Risk Factors; United States | 2015 |
Dysfunctional Default Mode Network in Methadone Treated Patients Who Have a Higher Heroin Relapse Risk.
Topics: Adult; Brain; Brain Mapping; Female; Follow-Up Studies; Heroin Dependence; Humans; Magnetic Resonance Imaging; Male; Methadone; Middle Aged; Neural Pathways; Radiography; Recurrence; Risk; Temporal Lobe | 2015 |
Brain white matter integrity in heroin addicts during methadone maintenance treatment is related to relapse propensity.
Topics: Adult; Brain; Diffusion Magnetic Resonance Imaging; Diffusion Tensor Imaging; Follow-Up Studies; Heroin Dependence; Humans; Longitudinal Studies; Male; Methadone; Narcotics; Opiate Substitution Treatment; Prognosis; Recurrence; White Matter | 2016 |
Regional homogeneity changes between heroin relapse and non-relapse patients under methadone maintenance treatment: a resting-state fMRI study.
Topics: Adult; Aftercare; Biomarkers; Brain; Brain Mapping; Caudate Nucleus; Heroin Dependence; Humans; Magnetic Resonance Imaging; Male; Methadone; Middle Aged; Narcotics; Opiate Substitution Treatment; Outcome Assessment, Health Care; Recurrence | 2016 |
Relapse to opioid use in opioid-dependent individuals released from compulsory drug detention centres compared with those from voluntary methadone treatment centres in Malaysia: a two-arm, prospective observational study.
Topics: Adolescent; Adult; Analgesics, Opioid; Counseling; Humans; Malaysia; Mandatory Programs; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Prospective Studies; Recurrence; Substance Abuse Treatment Centers; Treatment Failure; Voluntary Programs; Work | 2017 |
A 50-year-old woman addicted to heroin: review of treatment of heroin addiction.
Topics: Buprenorphine; Drug Therapy, Combination; Female; Heroin Dependence; History, 19th Century; History, 20th Century; Humans; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Recurrence; Self-Help Groups; United States | 2008 |
Peginterferon plus Ribavirin for chronic hepatitis C in opiate addicts on methadone/buprenorphine maintenance therapy.
Topics: Adolescent; Adult; Antiviral Agents; Buprenorphine; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Methadone; Middle Aged; Narcotics; Patient Compliance; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Recurrence; Ribavirin; RNA, Viral; Substance Abuse, Intravenous; Treatment Outcome; Young Adult | 2009 |
Character pathology and neuropsychological test performance in remitted opiate dependence.
Topics: Adult; Character; Female; Humans; Male; Methadone; Middle Aged; Neuropsychological Tests; Opioid-Related Disorders; Policy Making; Recurrence; Young Adult | 2008 |
Real-time electronic diary reports of cue exposure and mood in the hours before cocaine and heroin craving and use.
Topics: Adult; Affect; Ambulatory Care; Cocaine-Related Disorders; Combined Modality Therapy; Computers, Handheld; Counseling; Cues; Female; Heroin Dependence; Humans; Male; Methadone; Middle Aged; Motivation; Narcotics; Prospective Studies; Recurrence; Social Environment; Substance Withdrawal Syndrome; Token Economy; Young Adult | 2009 |
Maintenance therapy and 3-year outcome of opioid-dependent prisoners: a prospective study in France (2003-06).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Buprenorphine; Female; France; Humans; Male; Methadone; Middle Aged; Narcotic Antagonists; Opioid-Related Disorders; Prescription Drugs; Prisoners; Prisons; Prospective Studies; Recurrence; Young Adult | 2009 |
Gender difference in the treatment outcome of patients served in the mixed-gender program.
Topics: Adolescent; Adult; Female; Humans; Male; Methadone; Opioid-Related Disorders; Recurrence; Sex Factors; Treatment Outcome; Young Adult | 2009 |
Proportional hazards frailty models for recurrent methadone maintenance treatment.
Topics: Adult; Analgesics, Opioid; British Columbia; Confidence Intervals; Databases, Factual; Female; Heroin Dependence; Humans; Kaplan-Meier Estimate; Male; Methadone; Multivariate Analysis; Proportional Hazards Models; Recurrence; Statistics as Topic; Substance Abuse Treatment Centers | 2009 |
A delayed methadone encephalopathy: clinical and neuroradiological findings.
Topics: Brain; Child, Preschool; Encephalitis; Female; Humans; Magnetic Resonance Imaging; Methadone; Neurologic Examination; Neurotoxicity Syndromes; Recurrence | 2010 |
Premature discharge from methadone treatment: patient perspectives.
Topics: Adult; Appointments and Schedules; Counseling; Crime; Ethnicity; Female; Heroin Dependence; Humans; Life Change Events; Longitudinal Studies; Male; Maryland; Methadone; Narcotics; Opioid-Related Disorders; Patient Discharge; Patient Satisfaction; Prescription Fees; Recurrence; Socioeconomic Factors; Substance Abuse Treatment Centers; Workforce | 2009 |
[Displaced pain pump because of a pendulous abdomen - dermatolipectomy as solution of the problem].
Topics: Abdominal Fat; Adult; Amides; Analgesics, Opioid; Chronic Disease; Equipment Failure Analysis; Female; Foreign-Body Migration; Gastroplasty; Humans; Infusion Pumps, Implantable; Lipectomy; Methadone; Obesity, Morbid; Pain; Recurrence; Reoperation; Ropivacaine | 2010 |
Daily life hour by hour, with and without cocaine: an ecological momentary assessment study.
Topics: Adult; Affect; Cocaine; Cocaine-Related Disorders; Cohort Studies; Computers, Handheld; Female; Heroin Dependence; Humans; Male; Methadone; Middle Aged; Narcotics; Recurrence; Substance Withdrawal Syndrome; Time Factors; Young Adult | 2010 |
Resets do not appear to increase the rate of adverse events or prolong relapse in voucher-based reinforcement therapy.
Topics: Adult; Cocaine-Related Disorders; Female; Humans; Male; Methadone; Middle Aged; Proportional Hazards Models; Recurrence; Reinforcement Schedule; Substance Abuse Detection; Time Factors; Token Economy | 2010 |
Medical treatment of opioid dependence within the South African context.
Topics: Buprenorphine; Drug Combinations; Drug Overdose; Humans; Methadone; Motivation; Naloxone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Recurrence; South Africa; Substance Withdrawal Syndrome | 2010 |
Lapse and relapse following inpatient treatment of opiate dependence.
Topics: Adolescent; Adult; Aftercare; Age Factors; Analgesics, Opioid; Female; Follow-Up Studies; Humans; Interviews as Topic; Ireland; Male; Methadone; Opioid-Related Disorders; Prospective Studies; Recurrence; Risk Factors; Substance Abuse, Intravenous; Survival Analysis; Treatment Outcome | 2010 |
Addiction treatment in Russia.
Topics: Behavior, Addictive; Buprenorphine; Delayed-Action Preparations; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Recurrence; Russia; Substance Abuse, Intravenous; Suicide Prevention | 2010 |
Effect of prison-based opioid substitution treatment and post-release retention in treatment on risk of re-incarceration.
Topics: Adolescent; Adult; Humans; Longitudinal Studies; Male; Methadone; Narcotics; New South Wales; Opiate Substitution Treatment; Opioid-Related Disorders; Prisoners; Recurrence; Risk Factors; Young Adult | 2012 |
[Differences in depression severity and frequency of relapses in opiate addicts treated with methadone or opiate blocker after detoxification].
Topics: Adult; Depression; Humans; Male; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Recurrence; Young Adult | 2012 |
Association between cholesterol plasma levels and craving among heroin users.
Topics: Adult; Body Mass Index; Cholesterol; Female; Heroin; Heroin Dependence; Humans; Male; Methadone; Middle Aged; Motivation; Narcotics; Opiate Substitution Treatment; Recurrence; Risk Factors; Statistics as Topic; Substance Withdrawal Syndrome; Surveys and Questionnaires | 2012 |
An increase in overdose mortality during the first 2 weeks after entering or re-entering methadone treatment in Amsterdam.
Topics: Adult; Cohort Studies; Drug Overdose; Female; Heroin; Heroin Dependence; Humans; Male; Methadone; Narcotics; Netherlands; Recurrence; Time Factors | 2002 |
[Frequency of re-incarcerations in the same detention center: role of substitution therapy. A preliminary retrospective analysis].
Topics: Adult; Buprenorphine; Female; France; Heroin Dependence; Humans; Male; Methadone; Narcotic Antagonists; Prisoners; Recurrence; Retrospective Studies | 2002 |
Why do so many drug users smoke?
Topics: Adult; Causality; Comorbidity; Cross-Sectional Studies; Female; Focus Groups; Health Surveys; Heroin Dependence; Humans; Male; Mathematical Computing; Methadone; Middle Aged; Midwestern United States; Motivation; Narcotics; Recurrence; Smoking; Smoking Cessation; Tobacco Use Disorder | 2003 |
Predictors of drug treatment re-entry following relapse to cocaine use in DATOS.
Topics: Adult; Ambulatory Care; Black People; Cocaine-Related Disorders; Female; Follow-Up Studies; Humans; Length of Stay; Logistic Models; Male; Methadone; Outcome Assessment, Health Care; Patient Readmission; Recurrence; Retreatment; Risk Factors; Substance Abuse Treatment Centers; United States; Utilization Review; White People | 2003 |
A matched comparison study of medical and psychiatric complications and anesthesia and analgesia requirements in methadone-maintained liver transplant recipients.
Topics: Adult; Analgesics, Opioid; Comorbidity; Female; Hepatitis C; Humans; Liver Cirrhosis; Liver Transplantation; Male; Matched-Pair Analysis; Methadone; Middle Aged; Opioid-Related Disorders; Pain, Postoperative; Postoperative Period; Recurrence | 2004 |
Cycling in and out of treatment; participation in methadone treatment in NSW, 1990-2002.
Topics: Adult; Clinical Trials as Topic; Cohort Studies; Female; Heroin Dependence; Humans; Long-Term Care; Male; Methadone; Narcotics; New South Wales; Patient Dropouts; Recurrence; Retreatment; Retrospective Studies; Statistics as Topic | 2006 |
Linkage with methadone treatment upon release from incarceration: a promising opportunity.
Topics: Crime; Health Services Needs and Demand; Hepatitis B; Hepatitis C; HIV Infections; Humans; Long-Term Care; Methadone; Narcotics; Opioid-Related Disorders; Prisoners; Recurrence; Referral and Consultation; Risk; Substance Abuse, Intravenous; Tuberculosis, Pulmonary; United States | 2005 |
Longitudinal predictors of injection cessation and subsequent relapse among a cohort of injection drug users in Baltimore, MD, 1988-2000.
Topics: Adult; Baltimore; Cohort Studies; Female; HIV Infections; Humans; Ill-Housed Persons; Incidence; Longitudinal Studies; Male; Methadone; Patient Compliance; Prevalence; Recurrence; Smoking; Smoking Cessation; Smoking Prevention; Substance Abuse, Intravenous | 2006 |
How do treatment repeaters use the drug treatment system? An analysis of injection drug users in Massachusetts.
Topics: Adult; Female; Humans; Inactivation, Metabolic; Longitudinal Studies; Male; Massachusetts; Mental Health Services; Methadone; Narcotic Antagonists; Recurrence; Substance Abuse, Intravenous; Substance-Related Disorders | 2006 |
Determinants of health-related quality of life of opiate users at entry to low-threshold methadone programs.
Topics: Adolescent; Adult; Child Abuse; Child Abuse, Sexual; Cocaine-Related Disorders; Comorbidity; Female; Health Status Indicators; Humans; Hypnotics and Sedatives; Longitudinal Studies; Male; Mental Disorders; Methadone; Middle Aged; Ontario; Opioid-Related Disorders; Patient Acceptance of Health Care; Quality of Life; Recurrence; Retreatment; Statistics as Topic; Substance Abuse, Intravenous; Surveys and Questionnaires; Tranquilizing Agents; Treatment Outcome | 2006 |
Antidepressant treatment patterns in a novel methadone maintenance clinic targeting young adults an observational study.
Topics: Adolescent; Adult; Age Factors; Aged; Antidepressive Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Heroin Dependence; Humans; Male; Methadone; Middle Aged; Narcotics; New York City; Recurrence; Retrospective Studies; Sex Factors; Statistics as Topic; Substance Abuse Detection; Substance Abuse Treatment Centers; Treatment Outcome; Urban Population | 2006 |
Relapse to opioid use after treatment of chronic hepatitis C with pegylated interferon and ribavirin.
Topics: Antiviral Agents; Behavior, Addictive; Cocaine-Related Disorders; Comorbidity; Drug Administration Schedule; Follow-Up Studies; Hepatitis C, Chronic; Humans; Interferons; Male; Methadone; Middle Aged; Opioid-Related Disorders; Patient Care Planning; Recurrence; Ribavirin; Risk Assessment; Substance Abuse, Intravenous; Treatment Outcome | 2006 |
Mood disorders affect drug treatment success of drug-dependent pregnant women.
Topics: Adult; Diagnosis, Dual (Psychiatry); Diagnostic and Statistical Manual of Mental Disorders; Female; Humans; Methadone; Mood Disorders; Narcotic Antagonists; Opioid-Related Disorders; Pregnancy; Psychology; Recurrence; Severity of Illness Index; Social Behavior Disorders; Suicide, Attempted; Surveys and Questionnaires; Treatment Outcome | 2007 |
Problem drinking in relation to treatment outcome among opiate addicts in methadone maintenance treatment.
Topics: Adult; Alcohol Deterrents; Alcoholism; Comorbidity; Cyanamide; Disulfiram; Female; Follow-Up Studies; Humans; Hydroxyindoleacetic Acid; Hydroxytryptophol; Illicit Drugs; Male; Methadone; Narcotics; Opioid-Related Disorders; Patient Dropouts; Patient Readmission; Recurrence; Risk; Sex Factors; Substance Abuse Detection; Substance Abuse, Intravenous; Sweden | 2007 |
Chronic methadone treatment and repeated withdrawal impair cognition and increase the expression of apoptosis-related proteins in mouse brain.
Topics: Animals; Apoptosis Regulatory Proteins; Brain; Dose-Response Relationship, Drug; Male; Maze Learning; Memory; Methadone; Mice; Mice, Inbred C57BL; Motor Activity; Recurrence; Spatial Behavior; Substance Withdrawal Syndrome; Time Factors | 2007 |
An evaluation of a behaviour therapy programme as an intervention treatment for the fear of withdrawal with heroin-dependent persons.
Topics: Adult; Assertiveness; Behavior Therapy; Desensitization, Psychologic; Fear; Female; Follow-Up Studies; Heroin Dependence; Humans; Male; Methadone; Recurrence | 1980 |
Use of naltrexone to extinguish opioid-conditioned responses.
Topics: Adult; Combined Modality Therapy; Conditioning, Classical; Extinction, Psychological; Heroin Dependence; Humans; Male; Methadone; Naloxone; Naltrexone; Opioid-Related Disorders; Recurrence; Relaxation Therapy | 1984 |
Episodes of heroin use during maintenance treatment with stable dosage of (-)-alpha-acetylmethadol (methadyl acetate, LAAM).
Topics: Family; Heroin; Heroin Dependence; Humans; Life Style; Methadone; Methadyl Acetate; Recurrence | 1983 |
[Apropos of the Ministerial Order regulating methadone treatment].
Topics: Heroin Dependence; Humans; Legislation, Drug; Methadone; Recurrence; Rehabilitation Centers; Spain | 1983 |
Shutting off methadone. Costs and benefits.
Topics: Cost-Benefit Analysis; Crime; Female; Follow-Up Studies; Heroin Dependence; Humans; Male; Methadone; Recurrence | 1981 |
Relapse in opiate addicts: a behavioral analysis.
Topics: Adult; Cues; Humans; Interpersonal Relations; Male; Methadone; Motivation; Opioid-Related Disorders; Recurrence | 1982 |
Stressful life events and the return to heroin use.
Topics: Depression; Heroin Dependence; Humans; Life Change Events; Methadone; Recurrence | 1981 |
Drug abuse treatment readmissions and outcomes. Three-year follow-up of DARP patients.
Topics: Adolescent; Adult; Humans; Methadone; Outcome and Process Assessment, Health Care; Recurrence; Social Adjustment; Substance-Related Disorders; Therapeutic Community | 1980 |
Conditioned responses to drug-related stimuli: is context crucial?
Topics: Adult; Conditioning, Classical; Humans; Male; Methadone; Narcotics; Opioid-Related Disorders; Recurrence; Social Environment; Substance Abuse, Intravenous; Substance Withdrawal Syndrome; Treatment Outcome | 1995 |
[Report on the buprenorphine substitution experience in urban medicine in Belgium].
Topics: Belgium; Buprenorphine; Drug Prescriptions; France; Heroin Dependence; Humans; Methadone; Physicians, Family; Recurrence; Time Factors; Urban Population | 1994 |
[Can substitution practices be indicated in withdrawal programs for heroin addicts?].
Topics: Buprenorphine; Heroin Dependence; Humans; Inpatients; Methadone; Narcotics; Outpatients; Patient Compliance; Recurrence; Time Factors | 1994 |
Treatment process and relapse to opioid use during methadone maintenance.
Topics: Adult; Comorbidity; Female; Follow-Up Studies; Humans; Male; Methadone; Opioid-Related Disorders; Outcome and Process Assessment, Health Care; Prospective Studies; Recurrence; Substance Abuse Detection; Texas | 1994 |
Methadone maintenance in general practice: patients, workload, and outcomes.
Topics: Adult; Benzodiazepines; Counseling; Family Practice; Female; Humans; Male; Methadone; Narcotics; Patient Acceptance of Health Care; Recurrence; Scotland; Substance Abuse Treatment Centers; Substance Abuse, Intravenous; Treatment Outcome; Workload | 1994 |
Phases of treatment: a practical approach to methadone maintenance treatment.
Topics: Combined Modality Therapy; Health Care Rationing; Heroin Dependence; Humans; Long-Term Care; Methadone; Patient Care Team; Patient Compliance; Psychotherapy; Recurrence; Substance Withdrawal Syndrome | 1994 |
A 24-year follow-up of California narcotics addicts.
Topics: Adult; California; Cause of Death; Drug Overdose; Employment; Follow-Up Studies; Health Status; Humans; Male; Methadone; Middle Aged; Morbidity; Opioid-Related Disorders; Prisoners; Recurrence; Risk Factors; Sex Factors; Smoking; Social Control, Formal; Therapeutic Community | 1993 |
Correlates of drug injection behaviors among methadone outpatients.
Topics: Acquired Immunodeficiency Syndrome; Adult; Cocaine; Female; Health Knowledge, Attitudes, Practice; Heroin Dependence; Humans; Male; Methadone; Middle Aged; Needle Sharing; Recurrence; Risk-Taking; Substance Abuse, Intravenous | 1993 |
Exposure to methadone programs and heroin use.
Topics: Adult; Female; Heroin Dependence; Humans; Length of Stay; Male; Methadone; Outcome and Process Assessment, Health Care; Patient Dropouts; Prospective Studies; Recurrence; Risk Factors; Substance Abuse Detection | 1993 |
Treatment effectiveness for legally coerced versus voluntary methadone maintenance clients.
Topics: Adult; California; Commitment of Mentally Ill; Crime; Female; Follow-Up Studies; Heroin Dependence; Hispanic or Latino; Humans; Male; Methadone; Recurrence; Substance Abuse Detection | 1993 |
Methadone maintenance and recovery.
Topics: Follow-Up Studies; Heroin Dependence; Humans; Methadone; Opioid-Related Disorders; Outcome and Process Assessment, Health Care; Recurrence | 1993 |
Treatment outcomes for methadone clients receiving lump-sum payments at initiation of disability benefits.
Topics: Adult; Ambulatory Care; Cocaine; Disability Evaluation; Eligibility Determination; Female; Financial Management; HIV Infections; Humans; Income; Insurance, Disability; Male; Methadone; Middle Aged; Opioid-Related Disorders; Recurrence; San Francisco; Social Security; Substance Abuse Detection; Substance Abuse, Intravenous; Substance-Related Disorders; Treatment Outcome | 1996 |
Reducing parental risk factors for children's substance misuse: preliminary outcomes with opiate-addicted parents.
Topics: Adolescent; Adult; Child; Child of Impaired Parents; Child, Preschool; Cohort Studies; Female; Heroin Dependence; Humans; Male; Methadone; Multivariate Analysis; Outcome Assessment, Health Care; Parent-Child Relations; Parents; Random Allocation; Recurrence; Risk Factors; Substance-Related Disorders | 1997 |
Temporal patterns of heroin and cocaine use among methadone patients.
Topics: Adult; Age Factors; Analysis of Variance; Cluster Analysis; Cocaine-Related Disorders; Crime; Female; Heroin Dependence; Humans; Longitudinal Studies; Male; Methadone; Narcotics; New York City; Recurrence; Risk Factors; Surveys and Questionnaires; Time Factors; Unemployment | 1998 |
[Ambulatory opiate withdrawal].
Topics: Ambulatory Care; Buprenorphine; Hospitalization; Humans; Methadone; Narcotics; Opioid-Related Disorders; Recurrence; Risk Factors; Substance Withdrawal Syndrome | 1998 |
Prior treatment history and its impact on criminal recidivism.
Topics: Adult; Alcoholism; Antisocial Personality Disorder; Cocaine-Related Disorders; Combined Modality Therapy; Comorbidity; Crime; Female; Heroin Dependence; Humans; Male; Methadone; Middle Aged; Recurrence | 1999 |
Community reinforcement approach for combined opioid and cocaine dependence. Patterns of engagement in alternate activities.
Topics: Adult; Buprenorphine; Clinical Trials as Topic; Cocaine-Related Disorders; Community Networks; Counseling; Female; Humans; Male; Methadone; Narcotics; Opioid-Related Disorders; Recurrence; Social Support; Socioenvironmental Therapy; Temperance; Treatment Outcome; United States | 2000 |
Methadone maintenance and cessation of injecting drug use: results from the Amsterdam Cohort Study.
Topics: Adolescent; Adult; Cohort Studies; Dose-Response Relationship, Drug; Female; HIV Infections; Humans; Male; Methadone; Middle Aged; Narcotics; Netherlands; Prospective Studies; Recurrence; Substance Abuse, Intravenous | 2000 |
Factors predicting entry of injecting drug users into substance abuse treatment.
Topics: Adolescent; Adult; Comorbidity; Factor Analysis, Statistical; Female; Heroin Dependence; HIV Infections; HIV Seropositivity; Humans; Logistic Models; Male; Methadone; Middle Aged; Patient Acceptance of Health Care; Recurrence; Risk Factors; Risk-Taking; Sexual Behavior; Substance Abuse Treatment Centers; Substance Abuse, Intravenous | 2000 |
Changes in Millon Clinical Multiaxial Inventory scores among opiate addicts as a function of retention in methadone maintenance treatment and recent drug use.
Topics: Adult; Antisocial Personality Disorder; Anxiety Disorders; Female; Follow-Up Studies; Humans; Male; Mental Disorders; Methadone; Mood Disorders; Multivariate Analysis; Opioid-Related Disorders; Personality Disorders; Personality Inventory; Recurrence; Social Isolation; Substance Abuse Treatment Centers | 2000 |
The Key Extended Entry Program (KEEP): a methadone treatment program for opiate-dependent inmates.
Topics: Female; Heroin Dependence; Humans; Male; Methadone; Narcotics; Patient Selection; Prisoners; Recurrence | 2001 |
Risk factors associated with noncompliance with methadone substitution therapy (MST) and relapse among chronic opiate users in an Outer London community.
Topics: Adult; England; Female; Humans; Male; Methadone; Middle Aged; Motivation; Opioid-Related Disorders; Patient Compliance; Recurrence; Risk Factors; Substance Abuse, Intravenous | 2001 |
Conditioned heroin responses as an indication of readdiction liability.
Topics: Conditioning, Psychological; Heart Rate; Heroin Dependence; Humans; Methadone; Projective Techniques; Recurrence; Respiration; Skin Temperature | 1979 |
Naltrexone in the treatment of opiate dependence.
Topics: Adolescent; Adult; Follow-Up Studies; Forecasting; Heroin Dependence; Humans; Male; Methadone; Naloxone; Naltrexone; Narcotics; New York City; Psychotherapy; Receptors, Opioid; Recurrence; Substance Withdrawal Syndrome; Substance-Related Disorders | 1978 |
Therapeutic detoxification of adolescent heroin addicts.
Topics: Adolescent; Age Factors; Female; Follow-Up Studies; Heroin Dependence; Humans; Male; Methadone; New York City; Recurrence; Substance Withdrawal Syndrome; Time Factors | 1978 |
Methadone maintenance: long-term follow-up of detoxified patients.
Topics: Alcoholism; Evaluation Studies as Topic; Female; Follow-Up Studies; Humans; Male; Methadone; New York City; Recurrence; Substance-Related Disorders | 1978 |
Detoxification from methadone maintenance: risk factors associated with relapse to narcotic use.
Topics: Adult; Female; Humans; Male; Methadone; New York City; Prognosis; Recurrence; Risk; Substance-Related Disorders | 1978 |
Long-term outcome of patients treated with methadone maintenance.
Topics: Evaluation Studies as Topic; Female; Follow-Up Studies; Humans; Male; Methadone; New York City; Prognosis; Recurrence; Substance-Related Disorders | 1978 |
Ability to remain abstinent after methadone detoxification. A six-year study.
Topics: Ethnicity; Female; Follow-Up Studies; Humans; Male; Methadone; New York City; Recurrence; Remission, Spontaneous; Substance-Related Disorders; Time Factors | 1977 |
Evaluation methodology.
Topics: Behavior; Crime; Employment; Evaluation Studies as Topic; Heroin Dependence; Humans; Interpersonal Relations; Methadone; Methods; Mortality; Patient Dropouts; Personality; Recurrence; Social Adjustment | 1977 |
Evaluation of the 21-day outpatient heroin detoxification.
Topics: Adolescent; Adult; Counseling; Evaluation Studies as Topic; Heroin Dependence; Humans; Male; Methadone; Outpatient Clinics, Hospital; Patient Dropouts; Recurrence; Time Factors | 1977 |
Successful detoxification from methadone maintenance. Follow-up study of 38 patients.
Topics: Alcoholism; Drug Evaluation; Humans; Methadone; Recurrence; Social Adjustment; Substance Withdrawal Syndrome; Substance-Related Disorders | 1976 |
Experiences of a methadone detoxification programme for opium addicts.
Topics: Adult; Aged; Humans; Male; Methadone; Middle Aged; Opium; Recurrence; Substance-Related Disorders | 1976 |
Criminal activity, wages earned, and drug use after two years of methadone treatment.
Topics: Alcohol Drinking; California; Criminal Psychology; Employment; Humans; Income; Male; Methadone; Patient Dropouts; Prisoners; Recurrence; Substance-Related Disorders; Time Factors | 1975 |
Methadone dependence in the rat.
Topics: Animals; Body Weight; Humans; Male; Mathematics; Methadone; Rats; Recurrence; Substance Withdrawal Syndrome; Substance-Related Disorders | 1975 |
Heroin addiction. Sequential treatment employing pharmacologic supports.
Topics: Heroin Dependence; Humans; Methadone; Morphine; Naltrexone; Prognosis; Recurrence | 1976 |
Factors associated with relapse among opiate addicts in an out-patient detoxification programme.
Topics: Adult; Ambulatory Care; Female; Heroin Dependence; Humans; Male; Methadone; Opioid-Related Disorders; Patient Compliance; Recurrence; Risk Factors; Social Environment; Substance Abuse Detection | 1992 |
Improving treatment outcome in pregnant opiate-dependent women.
Topics: Adult; Combined Modality Therapy; Female; Fetal Growth Retardation; Follow-Up Studies; Heroin; Heroin Dependence; Humans; Infant, Newborn; Methadone; Neonatal Abstinence Syndrome; Outcome and Process Assessment, Health Care; Patient Care Team; Pregnancy; Pregnancy Complications; Prenatal Care; Recurrence; Social Environment; Substance Abuse Detection | 1992 |
[Critical comments on the contribution by N. Scherbaum and N. Gaspar. Substitution with methadone as a therapeutic approach in the treatment of drug dependent patients].
Topics: Follow-Up Studies; Heroin Dependence; Humans; Long-Term Care; Methadone; Opioid-Related Disorders; Recurrence | 1992 |
Social support and relapse: commonalities among alcoholics, opiate users, and cigarette smokers.
Topics: Adult; Alcoholism; Female; Follow-Up Studies; Humans; Male; Methadone; Middle Aged; Opioid-Related Disorders; Recurrence; Risk Factors; Smoking Cessation; Social Environment; Social Support; Substance Abuse Treatment Centers | 1991 |
Methadone maintenance and clonidine detoxification in the treatment of opiate addicts in Israel: suggesting evidence for cultural differences in the effectiveness of treatment modalities for opiate addiction.
Topics: Antidepressive Agents; Clonidine; Combined Modality Therapy; Cross-Cultural Comparison; Culture; Employment; Heroin Dependence; Israel; Longitudinal Studies; Methadone; Opioid-Related Disorders; Patient Dropouts; Psychotherapy; Recurrence; Substance Abuse Treatment Centers; United States | 1991 |
[The treatment of dependence in the therapeutic community].
Topics: Belgium; Female; Follow-Up Studies; Humans; Life Style; Male; Methadone; Recurrence; Substance Abuse Treatment Centers; Substance-Related Disorders; Therapeutic Community | 1990 |
Ineffective use of psychoactive drugs. Methadone treatment is no exception.
Topics: Humans; Methadone; Recurrence; Substance-Related Disorders; Treatment Outcome; Treatment Refusal | 1992 |
Methadone and edema.
Topics: Adult; Dose-Response Relationship, Drug; Edema; Heroin Dependence; Humans; Male; Methadone; Recurrence | 1991 |
A prospective assessment of opiate addiction treatment protocols for inpatients with HIV-related syndromes.
Topics: Adult; Combined Modality Therapy; Female; Follow-Up Studies; Heroin Dependence; HIV Infections; Hospitalization; Humans; Male; Methadone; Opportunistic Infections; Prospective Studies; Psychotherapy; Psychotropic Drugs; Recurrence; Substance Abuse, Intravenous | 1991 |
Unmet service needs in methadone maintenance.
Topics: Combined Modality Therapy; Community Mental Health Services; Consumer Behavior; Follow-Up Studies; Health Services Needs and Demand; Humans; Methadone; Opioid-Related Disorders; Recurrence; Rehabilitation, Vocational | 1991 |
Risk characteristics associated with chronic unemployment in methadone clients.
Topics: Adult; Female; Heroin Dependence; Humans; Male; Methadone; Recurrence; Rehabilitation, Vocational; Risk Factors; Unemployment | 1990 |
[Therapeutic treatment of drug dependence during hospital recovery].
Topics: Age Factors; Follow-Up Studies; Heroin Dependence; Hospitalization; Humans; Italy; Length of Stay; Methadone; Program Evaluation; Recurrence; Sex Factors; Socioeconomic Factors | 1990 |
Lapse, relapse and survival among opiate addicts after treatment. A prospective follow-up study.
Topics: Adolescent; Adult; England; Female; Follow-Up Studies; Heroin Dependence; Humans; Male; Methadone; Opioid-Related Disorders; Patient Admission; Prospective Studies; Recurrence | 1989 |
Circumstances surrounding the initial lapse to opiate use following detoxification.
Topics: Adolescent; Adult; Cues; Female; Follow-Up Studies; Heroin Dependence; Humans; Male; Methadone; Opioid-Related Disorders; Recurrence; Risk Factors; Social Environment | 1989 |
Cue exposure as an assessment technique in the management of a heroin addict: case report.
Topics: Adult; Arousal; Cues; Galvanic Skin Response; Heroin Dependence; Humans; Male; Methadone; Recurrence; Risk Factors | 1989 |
Classically conditioned responses in opioid and cocaine dependence: a role in relapse?
Topics: Cocaine; Conditioning, Classical; Humans; Methadone; Opioid-Related Disorders; Random Allocation; Recurrence; Substance-Related Disorders | 1988 |
Survival analysis in drug program evaluation. Part I. Overall program effectiveness.
Topics: Adult; Crime; Employment; Heroin Dependence; Humans; Male; Methadone; Outcome and Process Assessment, Health Care; Recurrence; Retrospective Studies; Statistics as Topic | 1987 |
Survival analysis in drug program evaluation. Part II. Partitioning treatment effects.
Topics: Crime; Humans; Methadone; Opioid-Related Disorders; Patient Compliance; Prognosis; Recurrence; Statistics as Topic; Unemployment | 1987 |
The antecedents and benefits of achieving abstinence in opioid addicts: a 2.5-year follow-up study.
Topics: Adult; Combined Modality Therapy; Female; Follow-Up Studies; Hospitals, University; Humans; Male; Methadone; Naltrexone; Opioid-Related Disorders; Psychiatric Department, Hospital; Recurrence; Social Adjustment | 1987 |
Fear of methadone maintenance.
Topics: Attitude to Health; Fear; Humans; Methadone; Opioid-Related Disorders; Outcome and Process Assessment, Health Care; Recurrence | 1987 |
[Hospital emergencies in drug addiction. Analysis and interpretation of data recorded at 3 DEAs of the Turin area].
Topics: Adolescent; Adult; Emergencies; Emergency Service, Hospital; Female; Humans; Italy; Male; Methadone; Recurrence; Seasons; Statistics as Topic; Substance-Related Disorders | 1986 |
Field observations of a heroin addict: a case study.
Topics: Activities of Daily Living; Adult; Behavior; Criminal Psychology; Drinking Behavior; Heroin Dependence; Humans; Interpersonal Relations; Male; Methadone; Recurrence; Rehabilitation Centers; Remission, Spontaneous; Sleep; Social Behavior; Social Environment | 1974 |
The ability to remain abstinent upon leaving methadone maintenance: a prospective study.
Topics: Adult; Age Factors; Ethnicity; Female; Heroin Dependence; Humans; Male; Methadone; Patient Dropouts; Prospective Studies; Recurrence; Remission, Spontaneous; Time Factors | 1974 |
Heroin addiction and the role of methadone in its treatment.
Topics: Animals; Anxiety; Compulsive Behavior; Conditioning, Classical; Conditioning, Operant; Dogs; Drug Tolerance; Haplorhini; Heroin; Humans; Life Style; Methadone; Mice; Morphine Dependence; Motivation; Narcotic Antagonists; Rats; Recurrence; Reward; Substance Withdrawal Syndrome; Time Factors | 1972 |
Methadone maintenance: myth and reality.
Topics: Costs and Cost Analysis; Criminal Psychology; Drug Tolerance; Evaluation Studies as Topic; Heroin; Humans; Methadone; Morphine Dependence; Recurrence; Remission, Spontaneous; Social Problems; Stress, Psychological; Substance Withdrawal Syndrome | 1972 |
Editorial: Detoxification of methadone patients, and public policy.
Topics: Chronic Disease; Follow-Up Studies; Humans; Methadone; Politics; Recurrence; Substance Withdrawal Syndrome; Substance-Related Disorders; Time Factors; United States; United States Food and Drug Administration | 1973 |
Recent developments in the therapy of addictions.
Topics: Amphetamine; Aversive Therapy; Barbiturates; Cocaine; Hallucinogens; Humans; Methadone; Nicotiana; Opium; Plants, Toxic; Recurrence; Substance-Related Disorders | 1972 |
Maintenance methadone treatment of drug dependency.
Topics: Administration, Oral; Adult; Constipation; Erectile Dysfunction; Evaluation Studies as Topic; Female; Heroin; Hospitalization; Humans; Male; Methadone; Middle Aged; Morphine Dependence; Narcotics; Psychotherapy; Recurrence; Social Adjustment; Substance Withdrawal Syndrome; Sweating | 1972 |
Resumption of morphine self-administration by ex-addict rats: an attempt to modify tendencies to relapse.
Topics: Animals; Disease Models, Animal; Drinking Behavior; Humans; Male; Methadone; Morphine; Morphine Dependence; Quinine; Rats; Recurrence; Reinforcement, Psychology; Substance Withdrawal Syndrome; Taste | 1972 |
Patterns of drop-outs from a methadone program for natcotic addicts.
Topics: Adult; Appointments and Schedules; Cooperative Behavior; Criminal Psychology; Employment; Evaluation Studies as Topic; Female; Heroin; Humans; Male; Methadone; Motivation; Narcotics; Outpatient Clinics, Hospital; Recurrence; Seasons; Social Adjustment; Social Behavior; Substance-Related Disorders | 1972 |
Evaluation of methadone maintenance treatment program.
Topics: Adolescent; Adult; Age Factors; Alcoholism; Community Mental Health Services; Drug and Narcotic Control; Educational Status; Employment; Ethnicity; Evaluation Studies as Topic; Female; Heroin; Humans; Male; Methadone; Middle Aged; Morphine Dependence; New York City; Recurrence; Social Behavior; Substance-Related Disorders | 1970 |
The natural history of narcotic drug addiction.
Topics: Adolescent; Adult; Age Factors; Drug and Narcotic Control; Female; Follow-Up Studies; Forensic Psychiatry; Heroin Dependence; Hospitalization; Humans; Male; Methadone; Middle Aged; Narcotics; Personality; Recurrence; Remission, Spontaneous; Sex Factors; Social Change; Substance-Related Disorders; Therapeutic Community; United States | 1970 |